Home/Filings/4/0001818382-24-000213
4//SEC Filing

Dougan Brady W 4

Accession 0001818382-24-000213

CIK 0001818382other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 7:30 AM ET

Size

7.7 KB

Accession

0001818382-24-000213

Insider Transaction Report

Form 4
Period: 2024-11-19
Transactions
  • Purchase

    Common Stock

    2024-11-19$4.44/sh+1,797$7,979243,851 total(indirect: By Spouse)
Holdings
  • Common Stock

    510,161
  • Common Stock

    (indirect: By LLC)
    1,730,884
  • Common Stock

    (indirect: By Trust)
    1,148,240
Footnotes (2)
  • [F1]This purchase by the Reporting Person's spouse is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person's spouse has paid the Issuer $8,778.23, representing the full amount of profit realized in connection with this purchase.
  • [F2]The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $4.435 to $4.4352. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Humacyte, Inc.

CIK 0001818382

Entity typeother

Related Parties

1
  • filerCIK 0001878020

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 7:30 AM ET
Size
7.7 KB